---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-023269"
form_type: "8-K"
ticker: null
cik: "0001907685"
company_name: "Comera Life Sciences Holdings, Inc."
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T20:08:37.163248+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Comera Life Sciences receives Nasdaq delisting notice for failing MVLS standard

## Summary
- Received Nasdaq determination letter on May 18, 2023 for non-compliance with $35M MVLS minimum.
- Grace period ended May 17, 2023; stock had not achieved $35M MVLS for 10 consecutive days.
- Must request hearing by May 25, 2023 to appeal; otherwise delisting on May 30, 2023.
- Company intends to request a hearing; trading will continue until Panel decision.
- If delisted, common stock expected to trade on OTC Markets Group.

## SEC filing metadata
- accession: 0000950170-23-023269
- form_type: 8-K
- cik: 0001907685
- company_name: Comera Life Sciences Holdings, Inc.
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907685/000095017023023269/0000950170-23-023269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907685/000095017023023269/cmra-20230518.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-023269
- JSON: https://secwatch.observer/filing/0000950170-23-023269.json
- Plain text: https://secwatch.observer/filing/0000950170-23-023269.txt

## Key facts
- Listing & Compliance Notices
  Comera Life Sciences Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: May 18, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) received a determination letter (the “Letter”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with the Market Value of Listed Securities (“MVLS”) Standard, since the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MLVS Rule”) and had not been at least $35 million for a minimum of 10 co
  evidence_url: https://www.sec.gov/Archives/edgar/data/1907685/000095017023023269/0000950170-23-023269-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.